byiShook Opinion
Sep 13, 2024 - 11:25
Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day. The post Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day appeared first on Investor's Business Daily.
Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.
The post Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day appeared first on Investor's Business Daily.